Onyx(美国)

Onyx Pharmaceuticals

美国OnyxPharmaceuticals,Inc.www.onyx-pharm.com2009Onyx将以8.51亿美元收购抗癌药开发商ProteolixOnyxPharmaceuticals,Inc.isabiopharmaceuticalcompanycommittedtoimprovingthelivesofpeoplewithcancer.Ourapprovedproduct,Nexav ar®(sorafenib)tablets,isanovel,oralmultiplekinaseinhibitorthattargetsproteinsinvolvedinbothtumorcellproliferationandangiogenesis.Nexavarisapprovedinmorethan80countriesforthetreatmentofpatientswithunresectablelivercancerandinmorethan90countriesforthetreatmentofpatientswithadvancedkidneycancer.Aspartofabroadclinicaldevelopmentprogram,NexavarisalsobeingevaluatedinmultiplePhase3andPhase2trialsasasingleagentorcombinationtreatmentinawiderangeofcancers,includinglungcancer,thyroidcancer,breastcancer,colorectalcancer,ovariancancer,andasanadjuvanttherapyforlivercancerandkidneycancer.Nexavarisbeingdevelopedandmarketedincollab